Waters Corporation

NYQ: WAT
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Waters Corporation's price action across multiple timeframes using regression channels and statistical scoring.

Get WAT Z-Score →

About Waters Corporation

Healthcare Diagnostics & Research
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

📊 Fundamental Analysis

Waters Corporation demonstrates exceptional profitability, with a profit margin of 20.3%.

The company recently reported 6.8% revenue growth, which is modest compared to its industry peers.

Return on Equity (ROE) is 29.3%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.

At a current price of $320.00, WAT currently sits at the 32nd percentile of its 52-week range (Range: $275.05 - $414.15).

💰 Valuation Insight

WAT is valued broadly in line with the sector at a PE of 29.77. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

Profit Margin Excellent
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
Return on Equity Excellent
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$31.41B
Trailing P/E
29.77
Forward P/E
19.57
Beta (5Y)
1.20
52W High
$414.15
52W Low
$275.05
Avg Volume
1.15M
Day High
Day Low
Get WAT Z-Score on Dashboard 🚀